Quarterly report pursuant to Section 13 or 15(d)

STOCK COMPENSATION (Tables)

v3.22.4
STOCK COMPENSATION (Tables)
 9 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Schedule of share-based compensation expense
                         
    Three Months
Ended
December 31,
2022		     Three Months
Ended
December 31,
2021		     Nine Months
Ended
December 31,
2022		     Nine Months
Ended
December 31,
2021		  
Vesting of stock options and restricted stock units   $ 262,613     $ 201,019     $ 791,588     $ 522,234  
Total stock-based compensation expense   $ 262,613     $ 201,019     $ 791,588     $ 522,234  
                                 
Weighted average number of common shares outstanding – basic and diluted     22,946,483       15,397,418       19,741,451       14,543,787  
                                 
Basic and diluted loss per common share attributable to stock-based compensation expense   $ (0.01 )   $ (0.01 )   $ (0.04 )   $ (0.04 )
Options outstanding that have vested and are expected to vest
                   
    Number of
Shares		     Weighted
Average
Exercise
Price		     Weighted
Average
Remaining
Contractual
Term in
Years		  
Vested     501,985     $ 2.83       7.83  
Expected to vest     1,201,848     $ 2.03       8.21  
Total     1,703,833                  
Schedule of stock option activity
                   
    Amount     Range of
Exercise Price		   Weighted
Average
Exercise
Price		  
Stock options outstanding at March 31, 2022     1,665,948     $ 1.28 - 142.50     $ 2.31  
Exercised     –     $ –     $ –  
Granted     61,600     $ 1.21     $ 1.21  
Cancelled/Expired     (23,715 )   $ 1.41 - 57     $ 2.85  
Stock options outstanding at December 31, 2022     1,703,833     $ 1.21 - 142.50     $ 2.26  
Stock options exercisable at December 31, 2022     501,985     $ 1.28 - 142.50     $ 2.83